Deals & business · 13h ago Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies 1 outlet CAR-T & cell therapy
Trials & R&D · 15h ago Chronic Kidney Disease Market: 5 Emerging Therapies to Watch as the Treatment Landscape Expected to Evolve by 2036 | DelveInsight 1 outlet CAR-T & cell therapy
Approvals & regulatory · 17h ago Kyverna steps closer to FDA-first CAR T for an autoimmune condition with durability data 1 outlet CAR-T & cell therapy FDA
Trials & R&D · 18h ago Kyverna builds case for CAR-T in stiff person syndrome 1 outlet CAR-T & cell therapy
Approvals & regulatory · 20h ago Kyverna says long-term data bolster FDA submission for rare autoimmune CAR-T 1 outlet CAR-T & cell therapy FDA
Trials & R&D · yesterday Off Script: Why Some CAR T Patients Develop Enterocolitis—and How to Treat It 1 outlet CAR-T & cell therapy
